Boothbay Fund Management LLC Raises Stock Position in Teleflex Incorporated (NYSE:TFX)

Boothbay Fund Management LLC raised its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 95.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 48,510 shares of the medical technology company's stock after buying an additional 23,728 shares during the period. Boothbay Fund Management LLC owned about 0.10% of Teleflex worth $8,634,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also added to or reduced their stakes in the company. Vontobel Holding Ltd. boosted its holdings in shares of Teleflex by 21.9% in the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company's stock valued at $248,000 after purchasing an additional 250 shares during the period. JPMorgan Chase & Co. raised its position in Teleflex by 14.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company's stock valued at $38,374,000 after purchasing an additional 19,466 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Teleflex by 5.2% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company's stock worth $19,263,000 after buying an additional 5,322 shares during the period. Lecap Asset Management Ltd. bought a new position in shares of Teleflex during the 4th quarter worth $729,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company's stock valued at $1,053,000 after buying an additional 1,527 shares during the period. 95.62% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

TFX has been the subject of a number of research reports. Wells Fargo & Company lowered their price objective on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research note on Friday, February 28th. Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and dropped their price objective for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. Mizuho set a $155.00 price objective on shares of Teleflex in a research note on Wednesday, April 16th. Raymond James cut Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $169.63.

Teleflex Stock Performance

Shares of Teleflex stock traded down $0.52 during midday trading on Monday, hitting $134.69. The company had a trading volume of 864,771 shares, compared to its average volume of 632,460. The stock has a market cap of $6.25 billion, a price-to-earnings ratio of 26.78, a PEG ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a 12-month low of $124.66 and a 12-month high of $249.91. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a fifty day simple moving average of $139.36 and a 200 day simple moving average of $172.78.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. As a group, analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio is presently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.